Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $24.1K $140.6K $248.0K $393.6K $360.6K
Cost of Revenue $1.1K $105.3K $72.8K $64.0K $70.1K
Gross Profit $23.0K $35.3K $175.1K $329.6K $290.5K
Gross Margin 95.4% 25.1% 70.6% 83.7% 80.6%
Operating Expenses
Research & Development $44.3K — — — —
SG&A Expense $401.3K $1.2M $1.1M $564.7K $544.5K
Operating Income $-2.0M $-3.6M $-5.9M $-2.6M $-3.7M
Operating Margin -8,109.4% -2,545.9% -2,367.5% -650.9% -1,033.1%
Interest Expense $2.5M $1.6M $1.1M $408.5K $860.3K
Pretax Income $-18.1M $-3.5M $-8.6M $-2.7M $-4.1M
Income Tax Expense $0 $0 $0 $0 $0
Net Income $-18.1M $-3.5M $-8.6M $-2.7M $-4.1M
Net Margin -75,114.9% -2,468.5% -3,462.7% -698.6% -1,124.5%
EPS (Basic) $-0.02 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $-0.02 — — — —
Shares Outstanding (Basic) 957.8M 39.27B 29.51B 108.19B 87.63B
Shares Outstanding (Diluted) 41.61B 41.63B 24.20B 26.73B 87.63B
Dividends Per Share — — — — —
← Newer Page 2 of 2 Older →